2025 Corporate Advisory Council

APSF is pleased to recognize the following companies for their exceptional level of support of APSF


2025 Corporate Advisory Council

Platinum Level ($60,000)

BDBD (bd.com)

Eagle PharmaceuticalsEagle Pharmaceuticals (eagleus.com)

Fresenius KabiFresenius Kabi (fresenius-kabi.us) is a global health care company that specializes in lifesaving medicines and technologies that are used to help care for critically and chronically ill patients, offering injectable medicine portfolios for anesthesia providers and a growing number of ready-to-administer products.

GE HealthcareGE Healthcare (gehealthcare.com) is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, that enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

SolventumSolventum (solventum.com) creates innovative products and services that touch millions of lives, transform the patient experience and save time for healthcare professionals.

Vertex PharmaceuticalsVertex Pharmaceuticals (vrtx.com). At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.

Gold Level ($40,000)

Blink Device Company
Blink Device Company

Medtronic
Nihon Kohden America
Nihon Kohden America

Preferred Physicians Medical Risk Retention Group

Silver Level ($15,000)

Dräger

Intelliguard

Merck

 

Special recognition and thank you to Medtronic for their support and funding of the APSF/Medtronic Patient Safety Research Grant ($150,000).

 

For more information about how your organization can support the APSF mission and participate in the Corporate Advisory Council, go to: apsf.org or contact Jill Maksimovich at: [email protected].